mRNA |
Bortezomib |
gCSI |
pan-cancer |
AAC |
0.017 |
0.8 |
mRNA |
Sunitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0097 |
0.8 |
mRNA |
BRD-K41597374 |
CTRPv2 |
pan-cancer |
AAC |
-0.0098 |
0.8 |
mRNA |
Ispinesib Mesylate |
GDSC1000 |
pan-cancer |
AAC |
-0.0088 |
0.8 |
mRNA |
PD173074 |
GDSC1000 |
pan-cancer |
AAC |
-0.0098 |
0.8 |
mRNA |
B02 |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.8 |
mRNA |
QL-VIII-58 |
GDSC1000 |
pan-cancer |
AAC |
-0.013 |
0.8 |
mRNA |
bid1870 |
gCSI |
pan-cancer |
AAC |
-0.015 |
0.8 |
mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.8 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0084 |
0.8 |